Oxford BioMedica

Oxford BioMedica

Gene and cell therapy group focused on developing life changing treatments for serious diseases.

Would it be accurate and relevant to link the text highlighted below to the topic CNSCNS?

Oxford BioMedica is a publicly traded, gene and cell therapy group based in Oxford, Oxforshire, UK. The company and its subsidiaries (the "Group") have build a lentiviral delivery platform (LentiVector), which the Group leverages to develop in vivo and ex vivo products, both in-house and with partners. Its portfolio ranges across the areas of oncology, opthalmology, and CNS disorders.

This text snippet is from the topic Oxford BioMedicaOxford BioMedica